West Pharmaceutical Services, Inc. (NYSE: WST) open the trading on Wednesday, with great promise as it jumped 0.01% to $286.44, before settling in for the price of $286.40 at the close. Taking a more long-term approach, WST posted a 52-week range of $265.00-$413.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 11.96%. Meanwhile, its Annual Earning per share during the time was 23.49%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -20.55%. This publicly-traded company’s shares outstanding now amounts to $73.50 million, simultaneously with a float of $72.12 million. The organization now has a market capitalization sitting at $20.78 billion.
West Pharmaceutical Services, Inc. (WST) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Instruments & Supplies industry. West Pharmaceutical Services, Inc.’s current insider ownership accounts for 0.59%, in contrast to 95.96% institutional ownership. According to the most recent insider trade that took place on Aug 19 ’24, this organization’s VP & Treasurer sold 1,029 shares at the rate of 300.00, making the entire transaction reach 308,700 in total value, affecting insider ownership by 1,478. Preceding that transaction, on May 10 ’24, Company’s Director sold 617 for 365.92, making the whole transaction’s value amount to 225,773. This particular insider is now the holder of 43,565 in total.
West Pharmaceutical Services, Inc. (WST) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.84 per share during the current fiscal year.
West Pharmaceutical Services, Inc.’s EPS decrease for this current 12-month fiscal period is -20.55% and is forecasted to reach 7.72 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 2.89% through the next 5 years, which can be compared against the 23.49% growth it accomplished over the previous five years trading on the market.
West Pharmaceutical Services, Inc. (NYSE: WST) Trading Performance Indicators
Let’s observe the current performance indicators for West Pharmaceutical Services, Inc. (WST). It’s Quick Ratio in the last reported quarter now stands at 1.68. The Stock has managed to achieve an average true range (ATR) of 6.91. Alongside those numbers, its PE Ratio stands at $40.74, and its Beta score is 1.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.22. Similarly, its price to free cash flow for trailing twelve months is now 58.19.
In the same vein, WST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 7.03, a figure that is expected to reach 1.50 in the next quarter, and analysts are predicting that it will be 7.72 at the market close of one year from today.
